OL
Oren Livnat HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Pacira BioSciences
PCRX
$1.2B
| $26.74 | $65 |
143%
upside
| Buy |
8 Apr ‘25
5 months ago |
|
2
Collegium Pharmaceutical
COLL
$1.19B
| $37.75 | $50 |
32%
upside
| Buy |
24 Mar ‘25
5 months ago |
|
3
Trevi Therapeutics
TRVI
$926M
| $7.60 | $12.50 |
64%
upside
| Buy |
19 Mar ‘25
5 months ago |
|
4
ANI Pharmaceuticals
ANIP
$2.06B
| $95.20 | $94 |
1%
downside
| Buy |
17 Mar ‘25
5 months ago |
|
5
Zevra Therapeutics
ZVRA
$468M
| $8.33 | $20 |
140%
upside
| Buy |
13 Mar ‘25
5 months ago |
|
6
Jazz Pharmaceuticals
JAZZ
$7.88B
| $129.85 | $217 |
67%
upside
| Buy |
10 Mar ‘25
6 months ago |
|
7
Xeris Biopharma Holdings
XERS
$1.25B
| $7.77 | $8 |
3%
upside
| Buy |
7 Mar ‘25
6 months ago |
|
|
AVDL
8
Avadel Pharmaceuticals
AVDL
$1.49B
| $15.38 | $21 |
37%
upside
| Buy |
4 Mar ‘25
6 months ago |
|
9
Tarsus Pharmaceuticals
TARS
$2.4B
| $56.89 | $73 |
28%
upside
| Buy |
26 Feb ‘25
6 months ago |
|
|
GRCE
10
Grace Therapeutics, Inc. Common Stock
GRCE
$44.8M
| $3.24 | $12 |
270%
upside
| Buy |
18 Feb ‘25
6 months ago |
|
11
MannKind Corp
MNKD
$1.71B
| $5.57 | $7.50 |
35%
upside
| Buy |
4 Jan ‘24
1 year ago |
|
12
SCYNEXIS
SCYX
$38.4M
| $0.9171 | $8 |
772%
upside
| Buy |
13 May ‘22
3 years ago |
|
13
Lipocine
LPCN
$15.8M
| $2.91 | $59.50 |
1,945%
upside
| Buy |
26 Aug ‘21
4 years ago |
|
14
VYNE Therapeutics
VYNE
$7.43M
| $0.2916 | $198 |
67,801%
upside
| Buy |
7 May ‘21
4 years ago |
|